Massive UK Vaccine Roll-Out Begins Showcasing Muscle of UK National Health Service 08/12/2020 Elaine Ruth Fletcher & J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 London. The cameras were focused on the face of 90 year-old Margaret Keenan, the first UK citizen to receive the newly approved Pfizer/BioNTech COVID-19 vaccine on Tuesday at University Hospital in the city of Coventry. After her jab, she passed through a corridor of applauding nurses. Behind her mask was the glint of a smile […] Continue reading -> World Health Assembly Debate On Improving Emergency Response – Warmup For Bigger Reforms? 10/11/2020 Elaine Ruth Fletcher The World Health Assembly on Tuesday approved a resolution calling to strengthen WHO and global preparedness for health emergencies – with few new teeth but lots of symbolism attached. The resolution makes a sweeping, but still largely ceremonial, call to countries and the WHO to reinvigorate systems of emergency preparedness, vulnerability assessment, alert, response, compliance […] Continue reading -> COVID Cases Climb To Record Peaks Ahead of US Presidential Elections Tuesday 02/11/2020 Elaine Ruth Fletcher New COVID-19 cases reached record worldwide peaks in the United States over the weekend, hitting 98,583 new cases on Friday – as debates over management of the pandemic also fueled intense political duels in the last, heated days of campaigning between US President Donald Trump and his Democratic Party contender, Joseph Biden. Hospitalizations were also […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Health Assembly Debate On Improving Emergency Response – Warmup For Bigger Reforms? 10/11/2020 Elaine Ruth Fletcher The World Health Assembly on Tuesday approved a resolution calling to strengthen WHO and global preparedness for health emergencies – with few new teeth but lots of symbolism attached. The resolution makes a sweeping, but still largely ceremonial, call to countries and the WHO to reinvigorate systems of emergency preparedness, vulnerability assessment, alert, response, compliance […] Continue reading -> COVID Cases Climb To Record Peaks Ahead of US Presidential Elections Tuesday 02/11/2020 Elaine Ruth Fletcher New COVID-19 cases reached record worldwide peaks in the United States over the weekend, hitting 98,583 new cases on Friday – as debates over management of the pandemic also fueled intense political duels in the last, heated days of campaigning between US President Donald Trump and his Democratic Party contender, Joseph Biden. Hospitalizations were also […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Cases Climb To Record Peaks Ahead of US Presidential Elections Tuesday 02/11/2020 Elaine Ruth Fletcher New COVID-19 cases reached record worldwide peaks in the United States over the weekend, hitting 98,583 new cases on Friday – as debates over management of the pandemic also fueled intense political duels in the last, heated days of campaigning between US President Donald Trump and his Democratic Party contender, Joseph Biden. Hospitalizations were also […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO: Brace Yourselves For Second Wave – COVID-19 Cases In Northern Hemisphere Accelerating 19/10/2020 Elaine Ruth Fletcher As the northern hemisphere enters winter, “COVID-19 cases are accelerating, particularly in Europe and North America,” said WHO’s Director General Dr Tedros Adhanom Ghebreyesus, speaking at a Monday press briefing. In words that echoed warnings from European officials last week, Dr Tedros and WHO’s health emergencies team stressed that governments need to double down on […] Continue reading -> Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Won’t Pursue Emergency Authorization for COVID-19 Vaccine Before Mid-November, Says CEO in Open Letter 16/10/2020 Madeleine Hoecklin Pfizer CEO, Albert Bourla, announced Friday in an open letter that the pharmaceutical company developing a COVID-19 vaccine will not request an emergency authorization before mid-November – meaning that the file of the vaccine candidate that is regarded as the front-runner in the global race to get a vaccine to market would only be reviewed […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy